1. Combination therapy with a Tmprss6 RNAi‐therapeutic and the oral iron chelator deferiprone additively diminishes secondary iron overload in a mouse model of β‐thalassemia intermedia. Issue 4 (April 2015) Authors: Schmidt, Paul J.; Racie, Tim; Westerman, Mark; Fitzgerald, Kevin; Butler, James S.; Fleming, Mark D. Journal: American journal of hematology Issue: Volume 90:Issue 4(2015:Apr.) Page Start: 310 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. RNAi‐mediated reduction of hepatic Tmprss6 diminishes anemia and secondary iron overload in a splenectomized mouse model of β‐thalassemia intermedia. Issue 6 (23rd March 2018) Authors: Schmidt, Paul J.; Liu, Kaifeng; Visner, Gary; Fitzgerald, Kevin; Fishman, Shannon; Racie, Tim; Hettinger, Julia L.; Butler, James S.; Fleming, Mark D. Journal: American journal of hematology Issue: Volume 93:Issue 6(2018:Jun.) Page Start: 745 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Small circular interfering RNAs (sciRNAs) as a potent therapeutic platform for gene-silencing. Issue 18 (11th September 2021) Authors: Jahns, Hartmut; Degaonkar, Rohan; Podbevsek, Peter; Gupta, Swati; Bisbe, Anna; Aluri, Krishna; Szeto, John; Kumar, Pawan; LeBlanc, Sarah; Racie, Tim; Brown, Christopher R; Castoreno, Adam; Guenther, Dale C; Jadhav, Vasant; Maier, Martin A; Plavec, Janez; Egli, Martin; Manoharan, Mu... Journal: Nucleic acids research Issue: Volume 49:Issue 18(2021) Page Start: 10250 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗